Select Countries

00
Select All
Clear All
Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde
Central African Rep
Chad
Comoros
Congo
Côte d’Ivoire
Djibouti
DRC
Egypt
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Lesotho
Liberia
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Rwanda
SADR
São Tomé and Príncipe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
South Sudan
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Zambia
Zimbabwe

Select Indicators

Clear All
00
Reproductive, Maternal, Neonatal and Child Health
Adolescent Fertility Rate
Births Attended by Skilled Personnel
Contraceptive Prevalence
Infant Mortality Rate
DPT3 Immunization Coverage in Children
Maternal Mortality Ratio
Neonatal Mortality Rate
Pregnant Women with 4 ANC Visits
Stunting Under 5 yrs
Under-5 Mortality Rate
Unmet Need for Family Planning
Women Who Received Post-partum Care
HIV and AIDS
Adults Tested for HIV and Know Status
HIV Knowledge (Men aged 15-24 yrs)
HIV Knowledge (Women aged 15-24 yrs)
HIV Patients Receiving Anti-retroviral Drugs
HIV Positive Pregnant Women who Receive Antiretrovirals
HIV and TB Treatment
HIV Prevalence (Females 15-24 yrs)
Pregnant Women Tested for HIV and Know Status
School Attendance of Orphans
Condom Use
Malaria and Tuberculosis
Malaria Incidence
Malaria Deaths
Pregnant Women who Received 3 Doses of IPT
Under 5s Treated with Anti-Malarial Drugs
Under 5s who Slept Under ITN
Under 5s with Fever in Last 2 Weeks Screened for Malaria
TB Case Detection Rate
TB Treatment Success Rate
Health Finance
General Gov Exp on Health as % of GGE
Out of Pocket Health Expenditure
Per Capita Public Funds for Health

Create Chart

 

 
 

Your Selection

Countries:
Indicators:
  • None selected
  • None selected

Indicator Title

Return

Indicator Information

Select Stats

Contact

Alphabetical order

Download
Print
What does it mean ?
Full Name:Percentage of HIV-positive pregnant women who received antiretroviral drugs
Full Unit:%
Year-range of Data:2014
Source:UNAIDS AIDSinfo
Link :http://aidsinfo.unaids.org/
Date Source Published:4th December 2015
Date Source Accessed:1st May 2016

The following countries had no data:
Cape Verde, Comoros, Guinea, Libya, Mauritius, Morocco, Niger, SADR, São Tomé and Príncipe, Seychelles, Sierra Leone, Tunisia

Alternative Data Sources

HIV Positive Pregnant Women who Receive Antiretrovirals

What does it mean ?

An antiretroviral drug is one that stops or suppresses the activity of retroviruses, such as HIV, in the body, and therefore reduces the chances of mother to child transmission of HIV. The indicator measures the percentage of HIV-infected pregnant women who received antiretroviral medicines, among the estimated number of HIV-infected pregnant women.

Why does it matter ?

HIV infection can be transmitted from an HIV-infected mother to her baby during pregnancy, labor and delivery, or through breastfeeding. In the absence of any preventative interventions, a child born to and then breastfed by an HIV-infected woman will have about a 1-in-3 changes of becoming infected. The risk of HIV transmission from mother to child is significantly reduced when antiretroviral medication is taken during pregnancy. Providing prophylaxis (a measure taken to prevent the spread of disease) to the infant, along with using safe delivery practices and safe infant feeding methods will reduce risk of transmission. The indicator is a measure of progress in preventing mother-to-child transmission of HIV (PMTCT).

How is it collected ?

Two pieces of information are needed: 1) number of HIV-infected pregnant women who received antiretroviral drugs during the past 12 months and 2) number of HIV-infected pregnant women during the past 12 months. The first is obtained from monitoring tools used by programmes, such as patient registers and reporting forms. The second from surveys used for the surveillance of antenatal clinics in conjunction with demographic data, or estimation models such as Spectrum.

Find out more about the Summary Definition and the Methodology for Collection and Calculation

Share this :

Close

Summary Definition, Methodology for Collection and Calculation

Alternative Data Sources

The data for each indicator on African Health Stats (AHS) are published by the UN agency, or UN inter-agency group, which holds responsibility for global monitoring of the indicator. This varies by indicator. Please refer to ‘Data Source’. AHS uses data from these sources because such data are internationally comparable and it is the mandate of those agencies to prepare such data and monitor progress internationally. In some cases the UN agency has made adjustments to the data in order to make national data internationally comparable, for example they may adjust national estimates to account for differences in survey design, the extent of potential underreporting, and the definition of what is being measured (eg. maternal deaths). This means that at times there may be discrepancies between national and international estimates. Individual countries may prefer to instead rely on national figures for national monitoring. For uniformity, AHS uses only international estimates of the UN agencies in data visualisations.

In 2014, the following countries communicated that they use alternative figures to monitor the indicator HIV Positive Pregnant Women who Receive Antiretrovirals instead of the figures that appear in AHS data visualisations. The most recent alternative figure supplied by these countries in 2014, by source are: Zimbabwe 2013 82 (no source).

Collection Summary

Two pieces of information are needed to calculate this indicator: 1) the number of HIV-infected pregnant women who received antiretroviral drugs during the past 12 months and 2) the estimated number of HIV-infected pregnant women during the past 12 months.

The first is obtained from monitoring tools used by programmes, such as patient registers and reporting forms. The second is obtained in two ways, either from surveys used for the surveillance of antenatal clinics in conjunction with demographic data, or estimation models such as the software package called Spectrum. Using these two estimates, the indicator is calculated by dividing the number of HIV-infected pregnant women who received antiretroviral drugs during the past 12 months by the number of HIV-infected pregnant women during the past 12 months.

Figures which are shown on AHS as 95% for this indicator are >95% on the UNAIDS Aidsinfo database.

For further information, download the Global AIDS Response Progress Reporting 2015: http://www.unaids.org/sites/default/files/media_asset/JC2702_GARPR2015guidelines_en.pdf

CARMMA African Union

This site is managed by the African Union's Department of Social Affairs

Language:

English

French

Keep up to date:

Twitter

Facebook